20 Charlotte Square
About Nodthera LimitedNodthera Limited is a biotech company focused on the discovery and development of novel inhibitors of the NLRP3 inflammasome.
CEO: Elizabeth Roper, PhD
4 articles with Nodthera Limited
Financing round led by Novo Ventures and includes new investors Cowen Healthcare Investments and Sanofi Ventures, as well as existing investors 5AM Ventures, F-Prime Capital, Sofinnova Partners and founding investor Epidarex Capital
U.K.-based NodThera is building up its war chest to develop therapies for diseases driven by chronic inflammation.
Nodthera, a U.K.-based startup, snagged $40 million (£28 million) in Series A funding.